Sandbox 20001
From Proteopedia
(Difference between revisions)
Line 2: | Line 2: | ||
<StructureSection load='6vsb' size='250' side='right' scene='83/839264/Covid-19_spike/1' caption='COVID-19 surface spike (PDB entry [[6vsb]])'> | <StructureSection load='6vsb' size='250' side='right' scene='83/839264/Covid-19_spike/1' caption='COVID-19 surface spike (PDB entry [[6vsb]])'> | ||
- | [[Image:Ezgif.com-Small crop.gif|left|230px|thumb|<span style="font-size:125%">Overall view of the COVID-19 virus. Note the spikes <span style="color:blue">blue</span> that adorn the outer surface,<span style="color:red">red</span>, which impart a '''corona''' like appearance. (Fusion Animation)</span>]]<br /> | + | [[Image:Ezgif.com-Small crop.gif|left|230px|thumb|<span style="font-size:125%">Overall view of the COVID-19 virus. Note the spikes <span style="color:blue">blue</span> that adorn the outer surface,<span style="color:red">red</span>, which impart a '''corona''' like appearance. (Fusion Animation).</span>]]<br /> |
Current revision
Coronavirus Disease 2019 (COVID-19)
|
References
- ↑ 1.0 1.1 1.2 Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Feb 19. pii: science.abb2507. doi: 10.1126/science.abb2507. PMID:32075877 doi:http://dx.doi.org/10.1126/science.abb2507
- ↑ Gordon, et al. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing: bioRxiv (online) 2020 http://doi.org/10.1101/2020.03.22.002386
- ↑ Gautret, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non-randomized clinical trial: Intl J Antimcrob Agents (in press) 2020 http://dx.doi.org/10.1016/j.ijantimicag.2020.105949
- ↑ Gao, et al. Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target: bioRxiv (online) 2020 https://doi.org/10.1101/2020.03.16.993386
- ↑ Jin, et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors: bioRxiv (online) 2020[1]
- ↑ Andersen, et al. The proximal origin of SARS-CoV-2: Nature Med (in press) 2020 http://dx.doi.org/10.1038/s41591-020-0820-9]
- ↑ Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 4. pii: science.abb2762. doi: 10.1126/science.abb2762. PMID:32132184 doi:http://dx.doi.org/10.1126/science.abb2762
- ↑ Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012. PMID:32147628 doi:http://dx.doi.org/10.5582/ddt.2020.01012